ENSG00000131183


Homo sapiens

Features
Gene ID: ENSG00000131183
  
Biological name :SLC34A1
  
Synonyms : Q06495 / SLC34A1 / solute carrier family 34 member 1
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 5
Strand: 1
Band: q35.3
Gene start: 177379235
Gene end: 177398848
  
Corresponding Affymetrix probe sets: 208177_at (Human Genome U133 Plus 2.0 Array)   217530_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000423022
Ensembl peptide - ENSP00000423733
Ensembl peptide - ENSP00000321424
NCBI entrez gene - 6569     See in Manteia.
OMIM - 182309
RefSeq - XM_017009775
RefSeq - NM_001167579
RefSeq - NM_003052
RefSeq - XM_005265975
RefSeq - XM_017009773
RefSeq Peptide - NP_003043
RefSeq Peptide - NP_001161051
swissprot - D6RCE5
swissprot - Q06495
swissprot - A0A024R7R9
Ensembl - ENSG00000131183
  
Related genetic diseases (OMIM): 612286 - Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286
  613388 - ?Fanconi renotubular syndrome 2, 613388
  616963 - Hypercalcemia, infantile, 2, 616963
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 slc34a1aENSDARG00000028824Danio rerio
 slc34a1bENSDARG00000054658Danio rerio
 SLC34A1ENSGALG00000003075Gallus gallus
 Slc34a1ENSMUSG00000021490Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
O95436 / SLC34A2 / solute carrier family 34 member 2ENSG0000015776555
Q8N130 / SLC34A3 / solute carrier family 34 member 3ENSG0000019856946


Protein motifs (from Interpro)
Interpro ID Name
 IPR003841  Sodium-dependent phosphate transport protein
 IPR029848  Sodium-dependent phosphate transport protein 2A


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0001503 ossification IEA
 biological_processGO:0001822 kidney development IEA
 biological_processGO:0006811 ion transport IEA
 biological_processGO:0006814 sodium ion transport IEA
 biological_processGO:0006817 phosphate ion transport IDA
 biological_processGO:0007584 response to nutrient IEA
 biological_processGO:0009100 glycoprotein metabolic process IEA
 biological_processGO:0010288 response to lead ion IDA
 biological_processGO:0030643 cellular phosphate ion homeostasis IBA
 biological_processGO:0032026 response to magnesium ion IEA
 biological_processGO:0032355 response to estradiol IEA
 biological_processGO:0033189 response to vitamin A IEA
 biological_processGO:0035725 sodium ion transmembrane transport IEA
 biological_processGO:0035864 response to potassium ion IEA
 biological_processGO:0042431 indole metabolic process IEA
 biological_processGO:0042493 response to drug IEA
 biological_processGO:0043434 response to peptide hormone IEA
 biological_processGO:0044267 cellular protein metabolic process TAS
 biological_processGO:0044341 sodium-dependent phosphate transport IEA
 biological_processGO:0045838 positive regulation of membrane potential IEA
 biological_processGO:0046686 response to cadmium ion IDA
 biological_processGO:0046689 response to mercury ion IDA
 biological_processGO:0051260 protein homooligomerization IEA
 biological_processGO:0055062 phosphate ion homeostasis IDA
 biological_processGO:0060416 response to growth hormone IEA
 biological_processGO:0071107 response to parathyroid hormone IEA
 biological_processGO:0071248 cellular response to metal ion IEA
 biological_processGO:0071374 cellular response to parathyroid hormone stimulus IEA
 biological_processGO:0072350 tricarboxylic acid metabolic process IEA
 biological_processGO:0072734 cellular response to staurosporine IEA
 biological_processGO:0097066 response to thyroid hormone IEA
 biological_processGO:0097187 dentinogenesis IEA
 biological_processGO:1901128 gentamycin metabolic process IEA
 biological_processGO:1901652 response to peptide IEA
 biological_processGO:1901684 arsenate ion transmembrane transport IEA
 biological_processGO:2000120 positive regulation of sodium-dependent phosphate transport IEA
 biological_processGO:2000187 positive regulation of phosphate transmembrane transport IEA
 cellular_componentGO:0005737 cytoplasm IBA
 cellular_componentGO:0005768 endosome IEA
 cellular_componentGO:0005886 plasma membrane TAS
 cellular_componentGO:0005887 integral component of plasma membrane NAS
 cellular_componentGO:0005903 brush border IBA
 cellular_componentGO:0009986 cell surface IEA
 cellular_componentGO:0016020 membrane IEA
 cellular_componentGO:0016021 integral component of membrane IEA
 cellular_componentGO:0016324 apical plasma membrane IDA
 cellular_componentGO:0016607 nuclear speck IDA
 cellular_componentGO:0031226 intrinsic component of plasma membrane IEA
 cellular_componentGO:0031526 brush border membrane NAS
 cellular_componentGO:0031982 vesicle IBA
 cellular_componentGO:0045121 membrane raft IEA
 cellular_componentGO:0048471 perinuclear region of cytoplasm IEA
 cellular_componentGO:0072686 mitotic spindle IDA
 molecular_functionGO:0005436 sodium:phosphate symporter activity IBA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0015293 symporter activity IEA
 molecular_functionGO:0015321 sodium-dependent phosphate transmembrane transporter activity TAS
 molecular_functionGO:0030165 PDZ domain binding IEA
 molecular_functionGO:0042803 protein homodimerization activity IEA


Pathways (from Reactome)
Pathway description
Type II Na+/Pi cotransporters
Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1)
Surfactant metabolism


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000083 Renal failure 
Show

 HP:0000103 Polyuria 
Show

 HP:0000114 Proximal renal tubule defect 
Show

 HP:0000117 Decreased renal tubular phosphate reabsorption 
Show

 HP:0000787 Kidney stones 
Show

 HP:0000938 Osteopenia "Osteopenia refers to a reduction in bone mineral density (BMD) below normal peak BMD but not low enough to be classified as osteoporosis. According to the WHO, osteopenia is characterized by a value of BMD more than 1 standard deviation below the young adult mean, but less than 2 standard deviations below this value." [HPO:curators]
Show

 HP:0000939 Osteoporosis "Osteoporosis is a systemic skeletal disease characterized by low bone density and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility. According to the WHO, osteoporosis is characterized by a value of BMD 2.5 standard deviations or more below the young adult mean." [HPO:curators]
Show

 HP:0001252 Muscular hypotonia "Muscular hypotonia is an abnormally low muscle tone (the amount of tension or resistance to movement in a muscle), often involving reduced muscle strength. Hypotonia is characterized by a diminished resistance to passive stretching." [HPO:curators]
Show

 HP:0001324 Muscle weakness "Reduced strength of muscles." [HPO:curators]
Show

 HP:0001508 Failure to thrive 
Show

 HP:0002148 Hypophosphatemia "A lower than normal level of blood phosphate." [HPO:curators]
Show

 HP:0002150 Hypercalciuria 
Show

 HP:0002659 Increased susceptibility to fractures "An abnormally increased tendency to fractures of bones caused by an abnormal reduction in bone strength that is generally associated with an increased risk of fracture." [HPO:sdoelken]
Show

 HP:0002748 Rickets 
Show

 HP:0002909 Generalized aminoaciduria 
Show

 HP:0003072 Hypercalcemia "A level of blood calcium that is higher than normal." [HPO:curators]
Show

 HP:0003076 Glycosuria "The excretion of abnormal amounts of glucose in the urine, generally resulting in osmotic diuresis." [HPO:curators]
Show

 HP:0003109 Hyperphosphaturia "An increased excretion of phosphates in the urine." [HPO:curators]
Show

 HP:0004322 Decreased body height "A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms)." [HPO:curators]
Show

 HP:0010639 Elevated alkaline phosphatase of bone origin "An abnormally increased level of bone isoforms of `alkaline phosphatase, tissue-nonspecific isozyme` (PRO:000003968) in the blood." [HPO:probinson]
Show

 HP:0012408 Medullary nephrocalcinosis "The deposition of calcium salts in the parenchyma of the renal medulla (innermost part of the kidney)." [ORDCID:0000-0001-5208-3432]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
No match






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr